The Microbiome and Cancer: The New Frontier
The human microbiome—the trillions of microbes living in and on us—is rapidly reshaping how we think about cancer. From prevention and risk, to treatment response and recurrence, high-quality research now shows the microbiome influences cancer biology and patient outcomes through immunity, metabolism, and inflammation. This field is moving fast; here’s a clear, evidence-linked guide to what we know (and what we still don’t). (JAMA Network, Science)
How the microbiome influences cancer
1. Immune modulation & inflammation
Microbes “train” our immune system. Some gut communities favour anti-tumour immunity by stimulating cytotoxic T cells, while others drive chronic inflammation that supports tumour growth. This immune–microbiome–oncology axis is now a central concept in cancer science. (Science)
2. Microbial metabolites: SCFAs & bile acids
When we eat fibre, gut bacteria produce short-chain fatty acids (SCFAs) like butyrate and propionate. These not only feed colon cells but also act as epigenetic regulators—switching genes on/off and modulating inflammation and cell growth. Dysregulated bile-acid metabolism, on the other hand, can generate carcinogenic by-products. (Nature, Frontiers)
3. Microbial genotoxins & DNA damage
Some bacteria produce genotoxins that directly damage DNA. For example, E. coli strains carrying the pks island produce colibactin, which leaves a distinct mutational “signature” in human colorectal tumours. This has recently been linked to early-onset colorectal cancer. (Nature)
Cancers with strongest microbiome links
Colorectal cancer (CRC)
CRC has the most robust evidence. Fusobacterium nucleatum is enriched in many CRC tumours and is associated with poorer survival. A 2024 analysis identified a secreted toxin (Fna C2) that helps Fusobacterium invade host cells, highlighting its role in recurrence risk. (Cancer.gov, ScienceDirect)
Breast cancer & the “estrobolome”
Gut microbes with estrogen-metabolising enzymes (the estrobolome) can reactivate estrogens in the gut, potentially influencing risk and tumour biology in ER+ breast cancer. Emerging data also show that endocrine therapies shift the breast tissue microbiome in protective ways. (Europe PMC, Oxford Academic, Cell)
Immunotherapy across cancers
Response to PD-1/PD-L1 checkpoint inhibitors in melanoma, lung, and kidney cancer is consistently linked to gut microbiome composition. Responder signatures often include Akkermansia muciniphila and Faecalibacterium spp. Antibiotics around treatment start are linked to worse outcomes. Early clinical trials even show that faecal microbiota transplantation (FMT) from responders can resensitise some non-responders. (Science, Cell, Taylor & Francis Online)
Tolerating treatment: side-effects the microbiome may shape
The microbiome also affects how patients cope with chemotherapy, radiotherapy, and immunotherapy. Dysbiosis has been linked to higher risks of mucositis, diarrhoea, and infections. Conversely, diverse, fibre-nourished microbiomes appear to support resilience. (Frontiers)
Prevention & recurrence risk: practical steps with evidence
1. Eat more fibre—and more kinds of plants
SCFAs from fibre support gut barrier integrity, immune balance, and anti-inflammatory signalling. A randomised trial showed fermented foods increased microbial diversity and lowered inflammation. Observational data (American Gut Project) found people eating ~30 different plant foods per week had greater microbial diversity. (Nature, Frontiers, ASM Journals)
2. Follow global cancer-prevention basics
The World Cancer Research Fund/AICR guidance—healthy weight, physical activity, plant-rich diets, limited alcohol, and minimal processed meat—remains the strongest evidence for lowering risk. These habits also nurture a healthier microbiome. (American Institute for Cancer Research)
3. Look after your mouth as well as your gut
The oral microbiome matters too. Periodontitis and specific oral-microbiome shifts have been linked to increased risk of pancreatic and other cancers. Daily dental hygiene and professional care are simple, sensible prevention steps. (Gut, Frontiers)
4. Be medication-savvy (with your oncology team)
Antibiotics around checkpoint inhibitor therapy may reduce benefit, and proton-pump inhibitors are also under scrutiny. Never stop or change medicines on your own—but ask your care team about timing and necessity. (Taylor & Francis Online, ASCO)
5. Fermented foods > retail probiotics (in most cases)
For most people, fermented foods (yoghurt/kefir, sauerkraut, kimchi, tempeh) are a safe, evidence-based way to build resilience. If you’re on chemotherapy, immunotherapy, or have a central line—do not start probiotics without oncology approval due to rare infection risks. (Frontiers, Memorial Sloan Kettering Cancer Center)
What about stool testing, oncology probiotics, or FMT?
- Stool testing: Commercial tests can show diversity but are not validated for predicting cancer outcomes.
- Oncology probiotics: Some specific strains are being studied, but routine use is not recommended outside trials.
- FMT: Early melanoma trials suggest promise for restoring immunotherapy response, but FMT is still experimental and available only in research settings. (Science, Cell)
A simple, evidence-aligned daily plan
- Plant diversity: Build meals around varied vegetables, legumes, fruits, nuts, seeds, and whole grains.
- Fibre first: Treat fibre like daily medicine for your gut and immune system.
- Fermented foods (when safe): Add yoghurt, kefir, kimchi, or sauerkraut if your care team agrees.
- Oral health: Keep up daily hygiene and routine dental care.
- Check medicines thoughtfully: Ask about timing and necessity of antibiotics/PPIs during treatment.
The bottom line
The microbiome is a genuine new frontier in oncology. It’s not a magic bullet, but it is a powerful influence on immunity, metabolism, and treatment response. Today, the most actionable steps are the basics: a fibre-rich, plant-diverse diet, fermented foods (when safe), strong oral hygiene, physical activity, and careful collaboration with your clinicians around medication use.
Cutting-edge therapies like FMT are promising but remain within clinical trials. The science is moving quickly—and what’s exciting is that much of the benefit may come from everyday, accessible choices that support both the microbiome and overall cancer resilience.
Key sources to explore
- JAMA Network – The microbiome in cancer prevention and treatment
- Science – Microbiome–immunity interactions and immunotherapy response
- Nature – Microbial metabolites and host regulation
- Frontiers in Immunology & Microbiology – SCFAs, bile acids, gut barrier health
- American Institute for Cancer Research – Lifestyle & cancer prevention
Ready to take the next step?
If you or a family member are navigating cancer treatment, you don’t have to do it alone. Supporting your microbiome and overall wellbeing can make a meaningful difference.
👉 Book a free 15-minute chat to discuss how naturopathic oncology support can enhance your treatment, reduce side-effects, and help you feel more resilient.
